Disease | Incidence Estimate | US people estimate | Statistic Used for Calculation |
| Sexually Transmitted Diseases (overall) |
approx 1 in 17 or 5.62% or 15.3 million people in USA |
15,300,000 |
65 million people living with an incurable STD (CDC)
|
| Syphilis |
approx 1 in 3,885 or 0.03% or 70,000 people in USA |
70,000 |
70,000 cases (NIAID; CDC 2001)
|
| HIV |
approx 1 in 6,800 or 0.01% or 40,000 people in USA |
40,000 |
approximately 40,000 annual cases in USA (NIAID)
|
| AIDS |
N/A |
N/A |
No information
|
| Genital herpes |
approx 1 in 544 or 0.18% or 500,000 people in USA |
499,999 |
500,000 new cases annually; 1 million annual cases (CDC 2001)
|
| Human Papillomavirus |
approx 1 in 49 or 2.02% or 5.5 million people in USA |
5,499,999 |
5.5 million new cases (NIAID/American Social Health Association)
|
| Chlamydia |
approx 1 in 68 or 1.47% or 4 million people in USA |
4,000,000 |
estimated 4 million cases (NIAID/CDC) [4-8 million cases] including undiagnosed (about 600,000 diagnosed).
|
| Gonorrhea |
approx 1 in 339 or 0.29% or 800,000 people in USA |
800,000 |
800,000 cases (CDC estimate/NIAID)
|
| HTLV |
N/A |
N/A |
No information
|
| chancroid |
approx 1 in 1,902,100 or 0.00% or 143 people in USA |
143 |
143 annual cases notified in USA 1999 (MMWR 1999); rare in the USA but with occasional outbreaks.
|
| cytomegalovirus |
N/A |
N/A |
No information
|
| molluscum contagiosum |
N/A |
N/A |
No information
|
| pubic lice |
approx 1 in 90 or 1.10% or 3 million people in USA |
3,000,000 |
3 million new cases annually estimated (NIAID)
|
| scabies |
N/A |
N/A |
No information
|
| Trichomoniasis |
approx 1 in 54 or 1.84% or 5 million people in USA |
5,000,000 |
5 million cases annually in the USA (CDC 2001)
|
| bacterial vaginosis |
N/A |
N/A |
No information
|
| Granuloma inguinale |
approx 1 in 1,000,000 or 0.00% or 272 people in USA |
272 |
0.1 new cases per 100,000 population of donovanosis was notified in Australia 2002 (Yohannes K, Roche P, Blumer C et al. 2004, Australia’s Health 2004, AIHW)
|
| Non-Specific Urethritis |
N/A |
N/A |
No information
|
| Hepatitis B |
approx 1 in 1,359 or 0.07% or 200,000 people in USA |
200,000 |
200,000 to 300,000 new cases in the USA 1990 (Digestive diseases in the United States: Epidemiology and Impact – NIH Publication No. 94-1447, NIDDK, 1994)
|
| Syphilis -- Teratogenic Agent |
N/A |
N/A |
No information
|
| Human carcinogen -- Chronic Hepatitis C viral infection |
N/A |
N/A |
No information
|
| Human carcinogen -- Human Immunodeficiency Virus Type 1 infection |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 16 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 18 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 31 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 35 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 39 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 45 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 51 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 52 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 56 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 58 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 59 |
N/A |
N/A |
No information
|
| Human carcinogen -- Infection with Human papillomavirus type 66 |
N/A |
N/A |
No information
|
| Hepatitis A |
approx 1 in 8,500 or 0.01% or 32,000 people in USA |
32,000 |
32,000 new cases in the USA 1992 (Digestive diseases in the United States: Epidemiology and Impact – NIH Publication No. 94-1447, NIDDK, 1994)
|
| Hepatitis C |
approx 1 in 1,813 or 0.06% or 150,000 people in USA |
150,000 |
150,000 new cases in the USA 1991 (Digestive diseases in the United States: Epidemiology and Impact – NIH Publication No. 94-1447, NIDDK, 1994)
|
| Viral Hepatitis |
approx 1 in 601 or 0.17% or 452,000 people in USA |
451,999 |
about 452,000 annual cases based on incidence of HepA, HepB, HepC, and HepD (NIDDK 1990-1992)
|
| Chronic Hepatitis B |
N/A |
N/A |
No information
|
| Chronic Hepatitis C |
N/A |
N/A |
No information
|
| Syphilitic aseptic meningitis |
N/A |
N/A |
No information
|
| Possible human carcinogenic exposure -- Human immunodeficiency virus type 2 |
N/A |
N/A |
No information
|
| Possible human carcinogenic exposure -- Human papillomavirus types 6 and 11 |
N/A |
N/A |
No information
|
| Possible human carcinogenic exposure -- Human papillomavirus genus beta |
N/A |
N/A |
No information
|
| HIV-1A |
N/A |
N/A |
No information
|
| HIV-1B |
N/A |
N/A |
No information
|
| HIV-2A |
N/A |
N/A |
No information
|
| HIV-1C |
N/A |
N/A |
No information
|
| HIV-2B |
N/A |
N/A |
No information
|
| HIV-1D |
N/A |
N/A |
No information
|
| HIV-1E |
N/A |
N/A |
No information
|
| HIV-1F |
N/A |
N/A |
No information
|
| HIV-1G |
N/A |
N/A |
No information
|
| HIV-1H |
N/A |
N/A |
No information
|
| HIV-1J |
N/A |
N/A |
No information
|
| HIV-1K |
N/A |
N/A |
No information
|
| HIV-1M |
N/A |
N/A |
No information
|
| HIV-1N |
N/A |
N/A |
No information
|
| HIV-1O |
N/A |
N/A |
No information
|
| HIV-1, CRF11_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF13_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF04_ cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF06_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF25_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF21_A2D |
N/A |
N/A |
No information
|
| HIV-1, CRF32_06A1 |
N/A |
N/A |
No information
|
| HIV-1, CRF16_ A2D |
N/A |
N/A |
No information
|
| HIV-1, CRF22_01A1 |
N/A |
N/A |
No information
|
| HIV-1, CRF26_AU |
N/A |
N/A |
No information
|
| HIV-2 |
N/A |
N/A |
No information
|
| HIV-1, CRF36_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF27_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF18_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF37_cpx |
N/A |
N/A |
No information
|
| HIV-1, CRF19_cpx |
N/A |
N/A |
No information
|
| Pediatric AIDS |
N/A |
N/A |
No information
|
| HIV-1A1 |
N/A |
N/A |
No information
|
| HIV-1A2 |
N/A |
N/A |
No information
|
| HIV-1A3 |
N/A |
N/A |
No information
|
| HIV-1F1 |
N/A |
N/A |
No information
|
| HIV-1F2 |
N/A |
N/A |
No information
|
| HIV-1, CRF01_AE |
N/A |
N/A |
No information
|
| HIV-1, CRF33_01B |
N/A |
N/A |
No information
|
| HIV-1, CRF31_BC |
N/A |
N/A |
No information
|
| HIV-1, CRF15_01B |
N/A |
N/A |
No information
|
| HIV-1, CRF34_01B |
N/A |
N/A |
No information
|
| HIV-1, CRF02_AG |
N/A |
N/A |
No information
|
| HIV-1, CRF30_0206 |
N/A |
N/A |
No information
|
| HIV-1, CRF20_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF12_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF41_CD |
N/A |
N/A |
No information
|
| HIV-1, CRF40_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF07_BC |
N/A |
N/A |
No information
|
| HIV-1, CRF35_AD |
N/A |
N/A |
No information
|
| HIV-1, CRF08_BC |
N/A |
N/A |
No information
|
| HIV-1, CRF42_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF23_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF14_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF24_BG |
N/A |
N/A |
No information
|
| HIV-1, CRF05_ D/F |
N/A |
N/A |
No information
|
| HIV-1, CRF43_02G |
N/A |
N/A |
No information
|
| HIV-1, CRF17_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF28_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF38_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF29_BF |
N/A |
N/A |
No information
|
| HIV-1, CRF39_BF |
N/A |
N/A |
No information
|
| Chlamydial Infection |
N/A |
N/A |
No information
|
| Tumours related to AIDS |
N/A |
N/A |
No information
|
| Pulmonary infections related to AIDS |
N/A |
N/A |
No information
|
| Opportunistic infections related to HIV infection |
N/A |
N/A |
No information
|
| Gastrointestinal infections related to AIDS |
N/A |
N/A |
No information
|
| HIV related skin conditions |
N/A |
N/A |
No information
|
| Neurological disorders related to AIDS |
N/A |
N/A |
No information
|
| HIV like Severe sore throat |
N/A |
N/A |
No information
|
| AIDS-Associated Nephropathy |
N/A |
N/A |
No information
|
| AIDS-Related Complex |
N/A |
N/A |
No information
|
| AIDS-Related Opportunistic Infections |
N/A |
N/A |
No information
|
| AIDS wasting syndrome |
N/A |
N/A |
No information
|
| AIDS Dementia Complex |
N/A |
N/A |
No information
|
| Vaginosis (bacterial vaginosis) |
N/A |
N/A |
No information
|
| Neurosyphilis -- general paresis |
N/A |
N/A |
No information
|
| Genital warts |
approx 1 in 272 or 0.37% or 1 million people in USA |
1,000,000 |
1 million annual cases in the USA (NIAID)
|
| HIV/AIDS |
approx 1 in 6,800 or 0.01% or 40,000 people in USA |
40,000 |
approximately 40,000 annual cases in USA (NIAID)
|
| Lymphoma, AIDS-related |
N/A |
N/A |
No information
|
| Lipodystrophy-HIV related |
N/A |
N/A |
No information
|
| Tinea cruris |
N/A |
N/A |
No information
|
| Ureaplasma urealyticum |
N/A |
N/A |
No information
|
| Lymphogranuloma venereum |
N/A |
N/A |
No information
|
| Primary syphilis |
N/A |
N/A |
No information
|
| Secondary syphilis |
N/A |
N/A |
No information
|
| Tertiary syphilis |
N/A |
N/A |
No information
|
| Congenital syphilis |
approx 1 in 489,208 or 0.00% or 556 people in USA |
556 |
556 annual cases notified in USA 1999 (MMWR 1999)
|
| HIV-associated eosinophilic folliculitis |
N/A |
N/A |
No information
|
| Treponema infection |
N/A |
N/A |
No information
|
| The clap |
N/A |
N/A |
No information
|
| Syphilis, latent |
N/A |
N/A |
No information
|
| Neurosyphilis |
N/A |
N/A |
No information
|
| Neurosyphilis -- asymptomatic |
N/A |
N/A |
No information
|
| Neurosyphilis -- tabes dorsalis |
N/A |
N/A |
No information
|
| Neurosyphilis -- meningovascular |
N/A |
N/A |
No information
|
| AIDS dysmorphic syndrome |
N/A |
N/A |
No information
|
| Condyloma |
N/A |
N/A |
No information
|
| Durand-Nicolas-Favre syndrome |
N/A |
N/A |
No information
|
In the United States, an estimated 15.3 million new cases of
sexually transmitted diseases (STDs) occur each year, at least
one-quarter of them among teenagers. (Source: excerpt from
The following statistics relate to the incidence of Sexually Transmitted Diseases:
The medical term 'incidence' of Sexually Transmitted Diseases usually refers
to the annual diagnosis rate of new cases of Sexually Transmitted Diseases.
Prevalence is a different medical disease measure that refers
to the estimated population
of people who are managing Sexually Transmitted Diseases at any given time (e.g. prevalence includes people who have had
a medical condition for a long time).
For more information on prevalence and incidence statistics, see about prevalence and incidence statistics.